Pirson S, Gautier-Isola M, Baudin L, Rouaud L, Vanwynsberghe A, Deroye J
Cell Mol Life Sci. 2025; 82(1):95.
PMID: 40011241
PMC: 11865408.
DOI: 10.1007/s00018-024-05542-3.
Tripathi S, Sharma Y, Kumar D
Metabol Open. 2025; 25:100347.
PMID: 39876904
PMC: 11772974.
DOI: 10.1016/j.metop.2025.100347.
Famta P, Shah S, Dey B, Kumar K, Bagasariya D, Vambhurkar G
Cancer Pathog Ther. 2025; 3(1):30-47.
PMID: 39872366
PMC: 11764040.
DOI: 10.1016/j.cpt.2024.01.001.
Haynes N, Chadwick T, Parker B
Nat Immunol. 2024; 25(10):1793-1808.
PMID: 39285252
DOI: 10.1038/s41590-024-01960-4.
Winkler J, Tan W, Diadhiou C, McGinnis C, Abbasi A, Hasnain S
J Clin Invest. 2024; 134(17).
PMID: 39225101
PMC: 11364385.
DOI: 10.1172/JCI164227.
The highly metastatic 4T1 breast carcinoma model possesses features of a hybrid epithelial/mesenchymal phenotype.
Herndon M, Ayers M, Gibson-Corley K, Wendt M, Wallrath L, Henry M
Dis Model Mech. 2024; 17(9).
PMID: 39104192
PMC: 11391819.
DOI: 10.1242/dmm.050771.
PP2A B55α inhibits epithelial-mesenchymal transition via regulation of Slug expression in non-small cell lung cancer.
Singh D, Qiu Z, Jonathan S, Fa P, Thomas H, Prasad C
Cancer Lett. 2024; 598:217110.
PMID: 38986733
PMC: 11670312.
DOI: 10.1016/j.canlet.2024.217110.
Integrating bulk RNA-seq and scRNA-seq analyses revealed the function and clinical value of thrombospondins in colon cancer.
Li J, Tang Y, Long F, Tian L, Tang A, Ding L
Comput Struct Biotechnol J. 2024; 23:2251-2266.
PMID: 38827236
PMC: 11140486.
DOI: 10.1016/j.csbj.2024.05.021.
The roles of PD-L1 in the various stages of tumor metastasis.
He Y, Zhu M, Lai X, Zhang H, Jiang W
Cancer Metastasis Rev. 2024; 43(4):1475-1488.
PMID: 38733457
DOI: 10.1007/s10555-024-10189-4.
Tumor-Extrinsic Axl Expression Shapes an Inflammatory Microenvironment Independent of Tumor Cell Promoting Axl Signaling in Hepatocellular Carcinoma.
Breitenecker K, Heiden D, Demmer T, Weber G, Primorac A, Hedrich V
Int J Mol Sci. 2024; 25(8).
PMID: 38673795
PMC: 11050718.
DOI: 10.3390/ijms25084202.
Cancer spreading patterns based on epithelial-mesenchymal plasticity.
Wang R, Yan Z
Front Cell Dev Biol. 2024; 12:1259953.
PMID: 38665432
PMC: 11043583.
DOI: 10.3389/fcell.2024.1259953.
Stress in the metastatic journey - the role of cell communication and clustering in breast cancer progression and treatment resistance.
Grasset E, Barille-Nion S, Juin P
Dis Model Mech. 2024; 17(3).
PMID: 38506114
PMC: 10979546.
DOI: 10.1242/dmm.050542.
Systematic analysis of integrated bioinformatics to identify upregulated THBS2 expression in colorectal cancer cells inhibiting tumour immunity through the HIF1A/Lactic Acid/GPR132 pathway.
Liu Y, Jiang C, Xu C, Gu L
Cancer Cell Int. 2023; 23(1):253.
PMID: 37884956
PMC: 10604812.
DOI: 10.1186/s12935-023-03103-5.
Enrichment of Activated Fibroblasts as a Potential Biomarker for a Non-Durable Response to Anti-Tumor Necrosis Factor Therapy in Patients with Crohn's Disease.
Park S, Lee G, Kim S, Lee C, Choi C, Kang S
Int J Mol Sci. 2023; 24(19).
PMID: 37834250
PMC: 10573580.
DOI: 10.3390/ijms241914799.
Update on Epithelial-Mesenchymal Plasticity in Cancer Progression.
Fontana R, Mestre-Farrera A, Yang J
Annu Rev Pathol. 2023; 19():133-156.
PMID: 37758242
PMC: 10872224.
DOI: 10.1146/annurev-pathmechdis-051222-122423.
Cancer cell plasticity during tumor progression, metastasis and response to therapy.
Perez-Gonzalez A, Bevant K, Blanpain C
Nat Cancer. 2023; 4(8):1063-1082.
PMID: 37537300
PMC: 7615147.
DOI: 10.1038/s43018-023-00595-y.
ΔNp63/p73 drive metastatic colonization by controlling a regenerative epithelial stem cell program in quasi-mesenchymal cancer stem cells.
Lambert A, Fiore C, Chutake Y, Verhaar E, Strasser P, Chen M
Dev Cell. 2022; 57(24):2714-2730.e8.
PMID: 36538894
PMC: 10002472.
DOI: 10.1016/j.devcel.2022.11.015.
Cell-specific bioorthogonal tagging of glycoproteins.
Cioce A, Calle B, Rizou T, Lowery S, Bridgeman V, Mahoney K
Nat Commun. 2022; 13(1):6237.
PMID: 36284108
PMC: 9596482.
DOI: 10.1038/s41467-022-33854-0.
Identification of Novel Molecular Subgroups in Esophageal Adenocarcinoma to Predict Response to Neo-Adjuvant Therapies.
Hoefnagel S, Koemans W, Khan H, Koster J, Meijer S, van Dieren J
Cancers (Basel). 2022; 14(18).
PMID: 36139661
PMC: 9496882.
DOI: 10.3390/cancers14184498.
Advances in the study of cancer metastasis and calcium signaling as potential therapeutic targets.
Cui C, Zhang Y, Liu G, Zhang S, Zhang J, Wang X
Explor Target Antitumor Ther. 2022; 2(3):266-291.
PMID: 36046433
PMC: 9400724.
DOI: 10.37349/etat.2021.00046.